Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8378) 8378
Publication (1952) 1952
Book / eBook (1683) 1683
Paper (949) 949
Report (196) 196
Newspaper Article (159) 159
Dissertation (65) 65
Book Chapter (60) 60
Book Review (51) 51
Conference Proceeding (49) 49
Magazine Article (18) 18
Data Set (13) 13
Trade Publication Article (4) 4
Newsletter (3) 3
Reference (2) 2
Technical Report (2) 2
Patent (1) 1
Video Recording (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3363) 3363
index medicus (3345) 3345
male (2088) 2088
female (2067) 2067
middle aged (1313) 1313
physics (1114) 1114
experiment (1110) 1110
adult (1099) 1099
animals (1061) 1061
aged (1052) 1052
research (997) 997
high energy physics - experiment (916) 916
particle physics (905) 905
analysis (841) 841
cern lhc coll (775) 775
experimental results (766) 766
article (761) 761
physics - high energy physics - experiment (760) 760
high energy physics (753) 753
risk factors (652) 652
p p: scattering (591) 591
medicine (580) 580
multidisciplinary sciences (566) 566
cms (554) 554
research article (540) 540
p p: colliding beams (528) 528
physics of elementary particles and fields (519) 519
health aspects (511) 511
studies (501) 501
cancer (479) 479
phenomenology (474) 474
genetic aspects (454) 454
mice (447) 447
united states (435) 435
history (419) 419
adolescent (410) 410
surgery (405) 405
oncology (404) 404
aged, 80 and over (400) 400
mortality (394) 394
medicine & public health (393) 393
science (389) 389
13000 gev-cms (386) 386
proteins (383) 383
abridged index medicus (382) 382
care and treatment (381) 381
cell biology (373) 373
physics, particles & fields (367) 367
diagnosis (364) 364
genetics & heredity (360) 360
nuclear experiment (354) 354
physiological aspects (353) 353
treatment outcome (352) 352
genetics (348) 348
medical research (348) 348
neurosciences (346) 346
biochemistry & molecular biology (332) 332
genomes (330) 330
particle physics - experiment (325) 325
young adult (323) 323
child (322) 322
gene expression (321) 321
disease (319) 319
life sciences (315) 315
risk (315) 315
hep (312) 312
biology (310) 310
hadron-hadron scattering (308) 308
mutation (303) 303
cardiac & cardiovascular systems (298) 298
clinical neurology (296) 296
genes (285) 285
prospective studies (283) 283
patients (282) 282
physical sciences (282) 282
genomics (280) 280
immunology (280) 280
scattering [p p] (277) 277
expression (275) 275
children (274) 274
natural sciences (274) 274
naturvetenskap (272) 272
medicine, general & internal (266) 266
epidemiology (265) 265
astronomy & astrophysics (263) 263
prognosis (255) 255
electronic books (250) 250
usage (248) 248
clinical trials (246) 246
prevalence (245) 245
physiology (243) 243
medicin och hälsovetenskap (235) 235
astrophysics (234) 234
cohort studies (233) 233
colliding beams [p p] (233) 233
medical and health sciences (233) 233
8000 gev-cms (229) 229
time factors (226) 226
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (223) 223
management (222) 222
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (721) 721
Gerstein Science - Stacks (311) 311
UTL at Downsview - May be requested (291) 291
UofT at Mississauga - Stacks (177) 177
Collection Dvlpm't (Acquisitions) - Vendor file (156) 156
UofT at Scarborough - Stacks (129) 129
St. Michael's College (John M. Kelly) - 2nd Floor (88) 88
Collection Dvlpm't (Acquisitions) - Closed Orders (85) 85
Victoria University E.J. Pratt - Stacks (78) 78
Trinity College (John W Graham) - Stacks (62) 62
St. Michael's College (John M. Kelly) - 3rd Floor (53) 53
OISE - Stacks (52) 52
Engineering & Comp. Sci. - Stacks (38) 38
Law (Bora Laskin) - Stacks (38) 38
Knox College (Caven) - Stacks (36) 36
Pontifical Inst. Mediaeval Studies - Library use only (35) 35
Victoria University E.J. Pratt - Reference (31) 31
Royal Ontario Museum - Stacks (28) 28
Victoria University Emmanuel College - Stacks (27) 27
Online Resources - Online (20) 20
Regis College - Stacks (20) 20
Robarts - Reference (20) 20
Trinity College (John W Graham) - Storage (20) 20
St. Augustine's Seminary - Stacks (19) 19
Earth Sciences (Noranda) - Stacks (16) 16
Music - Stacks (15) 15
New College (Ivey) - Stacks (15) 15
Trinity College (John W Graham) - Reference (12) 12
Thomas Fisher Rare Book - Rare Book (11) 11
University College (Laidlaw) - Stacks (11) 11
Gerstein Science - Reference (9) 9
Indust. Rel's & Hum. Resources (Newman) - Library use only (9) 9
Innis College - Stacks (9) 9
Victoria University CRRS - Library use only (9) 9
Mathematical Sciences - Stacks (8) 8
UofT at Mississauga - Reference (8) 8
Aerospace - Stacks (7) 7
Art - Library use only (7) 7
Astronomy & Astrophysics - Ask at library (7) 7
Physics - Stacks (7) 7
St. Michael's College (John M. Kelly) - Reference (7) 7
UofT at Scarborough - Withdrawn (7) 7
Criminology - Stacks (6) 6
Faculty of Information - Stacks (6) 6
Holland Bloorview Kids Rehabilitation - Stacks (6) 6
Massey College (Robertson Davies) - Rare Book (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Chemistry (A D Allen) - Stacks (4) 4
Dentistry (Harry R Abbott) - Withdrawn (4) 4
Faculty of Information - May be requested in 6-10 wks (4) 4
Lakeridge Health Sciences - Oshawa (4) 4
Music - Reference (4) 4
Providence Healthcare - Stacks (4) 4
Robarts - May be requested in 6-10 wks (4) 4
Royal Ontario Museum - Periodical Stacks (4) 4
Scarborough Hospital - General (4) 4
Victoria University E.J. Pratt - Rare Book (4) 4
Knox College (Caven) - Reference (3) 3
Music - Library use only (3) 3
OISE - Curriculum Resources (3) 3
Robarts - Library use only (3) 3
Robarts - Searching (3) 3
St. Michael's Hospital - Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
Aerospace - Reference (2) 2
Architecture Landscape (Shore + Moffat) - Reference (2) 2
Baycrest Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
Earth Sciences (Noranda) - Reference (2) 2
Engineering & Comp. Sci. - Reference (2) 2
Gerstein Science - Missing (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Innis College - Reference (2) 2
Institute for Christian Studies - Stacks (2) 2
OISE - Lost (2) 2
Robarts - Course Reserves (2) 2
Robarts - Government Pubs (2) 2
Robarts - Protected Material (2) 2
Royal Ontario Museum - Far Eastern Egyptian (2) 2
Scarborough Hospital - Birchmount (2) 2
Thomas Fisher Rare Book - Reference (2) 2
Trinity College (John W Graham) - Wycliffe Storage (2) 2
UofT Schools - Stacks (2) 2
UofT at Scarborough - May be requested in 6-10 wks (2) 2
UofT at Scarborough - Reference Desk (2) 2
Victoria University CRRS - Rare Book (2) 2
West Park Healthcare Centre - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Art - May be requested in 6-10 wks (1) 1
Baycrest Hospital - Resident/Client Library (1) 1
Baycrest Hospital - Wellness Library (1) 1
Business (Joseph L Rotman) - Ask at Reference Desk (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Credit Valley Hospital - Missing (1) 1
Criminology - Reference (1) 1
Dentistry (Harry R Abbott) - Circulation Desk (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Missing (1) 1
Earth Sciences (Noranda) - Oversize (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10415) 10415
German (169) 169
Spanish (114) 114
French (69) 69
Latin (30) 30
Portuguese (26) 26
Japanese (19) 19
Italian (9) 9
Czech (7) 7
Hebrew (6) 6
Arabic (5) 5
Chinese (4) 4
Ancient Greek (2) 2
Aramaic (2) 2
Danish (2) 2
Dutch (2) 2
Greek (2) 2
Turkish (2) 2
Catalan (1) 1
Kurdish (1) 1
Ottoman (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
by Martin, Daniel F., MD and Maguire, Maureen G., PhD and Fine, Stuart L., MD and Ying, Gui-shuang, PhD and Jaffe, Glenn J., MD and Grunwald, Juan E., MD and Toth, Cynthia, MD and Redford, Maryann, DDS, MPH and Ferris, Frederick L., MD and Comparison Age-related Macular
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 7, pp. 1388 - 1398
Objective To describe effects of ranibizumab and bevacizumab when administered monthly or as needed for 2 years and to describe the impact of switching to... 
Ophthalmology | OPHTHALMOLOGY | Macular degeneration | Care and treatment | Angiogenesis inhibitors | Drug therapy | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
by Grunwald, Juan E., MD and Daniel, Ebenezer, MBBS, MD and Huang, Jiayan, MS and Ying, Gui-shuang, PhD and Maguire, Maureen G., PhD and Toth, Cynthia A., MD and Jaffe, Glenn J., MD and Fine, Stuart L., MD and Blodi, Barbara, MD and Klein, Michael L., MD and Martin, Alison A and Hagstrom, Stephanie A., PhD and Martin, Daniel F., MD and CATT Res Grp and CATT Research Group
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 1, pp. 150 - 161
Purpose To describe risk factors for geographic atrophy (GA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Design Cohort... 
Ophthalmology | CATT | AREA | BEVACIZUMAB | SUSCEPTIBILITY | DISEASE | AMD | OPHTHALMOLOGY | RANIBIZUMAB | PROGRESSION | Follow-Up Studies | Geographic Atrophy - diagnosis | Humans | Middle Aged | Geographic Atrophy - drug therapy | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Genotyping Techniques | Bevacizumab | Incidence | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Visual Acuity - physiology | Fluorescein Angiography | Geographic Atrophy - epidemiology | Wet Macular Degeneration - epidemiology | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Factors | Proportional Hazards Models | Wet Macular Degeneration - diagnosis | Wet Macular Degeneration - drug therapy | Aged | Cohort Studies | Macular degeneration | Clinical trials | Physiological aspects | Comparative analysis | Drug therapy | Risk factors | Biomedical engineering | Medical research | Medicine, Experimental
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Author reply
by Hagstrom, Stephanie A., PhD and Ying, Gui-shuang, PhD and Maguire, Maureen G., PhD and Martin, Daniel F., MD
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 8, pp. e44 - e45
Ophthalmology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
by Ying, Gui-shuang, PhD and Huang, Jiayan, MS and Maguire, Maureen G., PhD and Jaffe, Glenn J., MD and Grunwald, Juan E., MD and Toth, Cynthia, MD and Daniel, Ebenezer, MBBS, MS, MPH and Klein, Michael, MD and Pieramici, Dante, MD and Wells, John, MD and Martin, Daniel F., MD and Comparison Age-Related Macular and Comparison of Age-related Macular Degeneration Treatments Trials Research Group
Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 1, pp. 122 - 129
Objective To determine the baseline predictors of visual acuity (VA) outcomes 1 year after treatment with ranibizumab or bevacizumab for neovascular... 
Ophthalmology | OPHTHALMOLOGY | HEMORRHAGE | SUBGROUP ANALYSIS | Antibodies, Monoclonal, Humanized - therapeutic use | Intravitreal Injections | Tomography, Optical Coherence | Humans | Middle Aged | Male | Treatment Outcome | Wet Macular Degeneration - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Wet Macular Degeneration - drug therapy | Time Factors | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Aged | Visual Acuity - physiology | Cohort Studies | Fluorescein Angiography | Macular degeneration | Physiological aspects | Medical colleges | Angiogenesis inhibitors | Consulting services
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
by Grunwald, Juan E., MD and Pistilli, Maxwell, MS and Ying, Gui-shuang, PhD and Maguire, Maureen G., PhD and Daniel, Ebenezer, MBBS, MD and Martin, Daniel F., MD and Comparison Age Related Macular Deg and Comparison of Age-related Macular Degeneration Treatments Trials Research Group
Ophthalmology, ISSN 0161-6420, 2015, Volume 122, Issue 4, pp. 809 - 816
Purpose To evaluate the growth of geographic atrophy (GA) during anti–vascular endothelial growth factor (VEGF) therapy. Design Cohort within a clinical trial.... 
Ophthalmology | ARMS2 | CFH | BEVACIZUMAB | RPE | SUSCEPTIBILITY | DISEASE | OPHTHALMOLOGY | RISK | PIGMENT EPITHELIAL ATROPHY | RANIBIZUMAB | PROGRESSION | Geographic Atrophy - genetics | Intravitreal Injections | Humans | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Wet Macular Degeneration - genetics | Bevacizumab | Ranibizumab | Serine Endopeptidases - genetics | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Toll-Like Receptor 3 - genetics | Complement C3 - genetics | Visual Acuity - physiology | Fluorescein Angiography | Antibodies, Monoclonal, Humanized - therapeutic use | High-Temperature Requirement A Serine Peptidase 1 | Photography | Proteins - genetics | Wet Macular Degeneration - diagnosis | Geographic Atrophy - pathology | Wet Macular Degeneration - drug therapy | Aged | Polymorphism, Single Nucleotide | Complement Factor H - genetics | Cohort Studies | Macular degeneration | Growth | Physiological aspects | Clinical trials | Comparative analysis | Drug therapy | Vascular endothelial growth factor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
by Daniel, Ebenezer, MBBS, PhD and Toth, Cynthia A., MD and Grunwald, Juan E., MD and Jaffe, Glenn J., MD and Martin, Daniel F., MD and Fine, Stuart L., MD and Huang, Jiayan, MS and Ying, Gui-shuang, MD, PhD and Hagstrom, Stephanie A., PhD and Winter, Katrina, BS and Maguire, Maureen G., PhD and Comparison of Age-related Macular and Comparison of Age-related Macular Degeneration Treatments Trials Research Group
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 3, pp. 656 - 666
Objective To describe risk factors for scar in eyes treated with ranibizumab or bevacizumab for neovascular age-related macular degeneration (AMD). Design... 
Ophthalmology | GLAUCOMA FILTRATION SURGERY | SUBRETINAL HEMORRHAGE | PHOTODYNAMIC THERAPY | VISUAL FUNCTION | BEVACIZUMAB | OPHTHALMOLOGY | RETINAL ANGIOMATOUS PROLIFERATION | NATURAL-HISTORY | CHOROIDAL NEOVASCULARIZATION | RANIBIZUMAB | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Cicatrix - etiology | Intravitreal Injections | Humans | Middle Aged | Male | Cicatrix - diagnosis | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Wet Macular Degeneration - genetics | Bevacizumab | Incidence | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Female | Postoperative Complications | Visual Acuity - physiology | Fluorescein Angiography | Antibodies, Monoclonal, Humanized - therapeutic use | Tomography, Optical Coherence | Risk Factors | Genotype | Wet Macular Degeneration - diagnosis | Wet Macular Degeneration - drug therapy | Fibrosis | Retina - pathology | Cohort Studies | Macular degeneration | Clinical trials | Physiological aspects | Comparative analysis | Drug therapy | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials
by Jaffe, Glenn J., MD and Martin, Daniel F., MD and Toth, Cynthia A., MD and Daniel, Ebenezer, MPH, PhD and Maguire, Maureen G., PhD and Ying, Gui-Shuang, PhD and Grunwald, Juan E., MD and Huang, Jiayan, MS and Comparison Age-related Macular and Comparison of Age-related Macular Degeneration Treatments Trials Research Group
Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 9, pp. 1860 - 1870
Objective To describe the effects of treatment for 1 year with ranibizumab or bevacizumab on macular morphology and the association of macular morphology with... 
Ophthalmology | OPHTHALMOLOGY | OPTICAL COHERENCE TOMOGRAPHY | BEVACIZUMAB | RANIBIZUMAB | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Follow-Up Studies | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Humans | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Ranibizumab | Subretinal Fluid | Angiogenesis Inhibitors - therapeutic use | Visual Acuity - physiology | Fluorescein Angiography | Macula Lutea - pathology | Macular degeneration | Clinical trials | Comparative analysis | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights